- Home
- DATS vs CVM Comparison
DATS vs CVM Comparison
Compare DATS & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DATS
- CVM
- Stock Information
- Founded
- DATS 2014
- CVM 1983
- Country
- DATS United States
- CVM United States
- Employees
- DATS N/A
- CVM N/A
- Industry
- DATS Computer Software: Prepackaged Software
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DATS Technology
- CVM Health Care
- Exchange
- DATS Nasdaq
- CVM Nasdaq
- Market Cap
- DATS 13.4M
- CVM 11.8M
- IPO Year
- DATS 2021
- CVM 1987
- Fundamental
- Price
- DATS $2.56
- CVM $3.46
- Analyst Decision
- DATS
- CVM
- Analyst Count
- DATS 0
- CVM 0
- Target Price
- DATS N/A
- CVM N/A
- AVG Volume (30 Days)
- DATS 211.3K
- CVM 1.6M
- Earning Date
- DATS 08-13-2025
- CVM 08-14-2025
- Dividend Yield
- DATS N/A
- CVM N/A
- EPS Growth
- DATS N/A
- CVM N/A
- EPS
- DATS N/A
- CVM N/A
- Revenue
- DATS $388.00
- CVM N/A
- Revenue This Year
- DATS N/A
- CVM N/A
- Revenue Next Year
- DATS N/A
- CVM N/A
- P/E Ratio
- DATS N/A
- CVM N/A
- Revenue Growth
- DATS N/A
- CVM N/A
- 52 Week Low
- DATS $1.04
- CVM $1.98
- 52 Week High
- DATS $9.34
- CVM $66.60
- Technical
- Relative Strength Index (RSI)
- DATS 48.61
- CVM 57.66
- Support Level
- DATS $2.58
- CVM $2.24
- Resistance Level
- DATS $2.85
- CVM $2.71
- Average True Range (ATR)
- DATS 0.14
- CVM 0.51
- MACD
- DATS 0.00
- CVM 0.25
- Stochastic Oscillator
- DATS 50.89
- CVM 25.61
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.